Ischemic Conditioning Improves Walking Function Post Stroke
1 other identifier
interventional
132
1 country
2
Brief Summary
This innovative study will address scientific and clinical areas relatively unexplored in chronic stroke that could lead to greater recovery of walking. Ischemic Conditioning (IC) is a non-invasive, simple procedure that improves motor function, exercise performance and cardiovascular function in healthy controls, but it has never been applied to the stroke population. We postulate that IC enhances the recruitment of motoneurons and results in positive neural adaptations, improves vascular endothelial function and peripheral blood flow, and together these improvements result in an increased capacity to exercise and faster walking speed. Future studies will examine the effects of IC and traditional therapy at different time points of recovery post stroke, durability of IC, molecular mechanisms of neural and cardiovascular adaptation and the efficacy compared with other adjuncts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Dec 2018
Longer than P75 for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2018
CompletedFirst Submitted
Initial submission to the registry
July 25, 2019
CompletedFirst Posted
Study publicly available on registry
July 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2026
CompletedMay 4, 2026
April 1, 2026
7 years
July 25, 2019
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self Selected Walking Speed
We will measure how fast participants walk during the 10 meter walk test.
Change from baseline to 4 weeks.
Secondary Outcomes (4)
Knee Extensor Leg Strength
Change from baseline to 4 weeks.
Knee Extensor Fatigability
Change from baseline to 4 weeks.
Flow Mediated Dilation of Non-Paretic Brachial Artery and Paretic Popliteal Artery
Change from baseline to 4 weeks.
Peak Oxygen Consumption
Change from baseline to 4 weeks.
Other Outcomes (14)
Six minute walk test
Change from baseline to 4 weeks.
Lower Extremity Fugl Meyer
Change from baseline to 4 weeks.
Manual Muscle Test
Change from baseline to 4 weeks.
- +11 more other outcomes
Study Arms (4)
Ischemic Conditioning + Treadmill Training
EXPERIMENTALStudy participants with prior history of stroke will receive both ischemic conditioning and treadmill training.
Ischemic Conditioning Sham + Treadmill Training
PLACEBO COMPARATORStudy participants with prior history of stroke will receive both ischemic conditioning sham and treadmill training.
Ischemic Conditioning Only
ACTIVE COMPARATORStudy participants with prior history of stroke will receive only ischemic conditioning.
Healthy Control - Ischemic Conditioning + Treadmill Training
ACTIVE COMPARATORHealthy control participants will receive both ischemic conditioning and treadmill training.
Interventions
Ischemic conditioning is a well-defined, non-invasive procedure which consists of inflating a blood pressure cuff around a limb (in our study, the paretic leg), inflating the cuff to 225 mmHg to occlude blood flow to the limb for 5 minutes, releasing the cuff for 5 minutes, and repeating 5 times. In our study, participants assigned to the IC Only and IC + Treadmill Training groups will undergo twelve sessions of ischemic conditioning over a four-week period.
Ischemic conditioning sham consists of the same setup as ischemic conditioning, which consists of inflating a blood pressure cuff around a limb (in our study, the paretic leg), inflating the cuff to 10 mmHg for 5 minutes, releasing the cuff for 5 minutes, and repeating 5 times. 10 mmHg is a sufficient inflation pressure for study participants to perceive some cuff tightness, but is not high enough to occlude blood flow. In our study, participants assigned to the IC Sham + Treadmill Training groups will undergo twelve sessions of ischemic conditioning sham over a four-week period.
Participants will perform 3 treadmill training sessions/week for a 4 week period (12 sessions total). Treadmill training will immediately follow IC or IC Sham. Personnel performing the treadmill training will be blinded to the IC treatment group. Subjects will walk on a treadmill for six, 5-minute intervals. Walking speed will be continuously adjusted to maintain heart rate between 50% and 60% of age-adjusted heart rate reserve to minimize the confounder of intensity. If individuals cannot walk at 80% of their overground self-selected walking speed, for 5 minutes, they will be assisted into a body weight support harness. Body weight support will be adjusted (up to 50%) such that individuals can walk at 80% of their over ground walking speed for five minutes and adjusted accordingly throughout the session. Participants assigned to the Treadmill + IC and Treadmill + IC Sham groups will receive Treadmill Training.
Eligibility Criteria
You may qualify if:
- be ≥ 1 year post diagnosis of a unilateral, cortical stroke and have residual lower extremity paresis
- be between the ages of 18-85
- be able to give informed consent
- walk slower than normative values based on age and sex
You may not qualify if:
- history of deep vein thrombosis or any condition in which transient ischemia to the lower extremity is contraindicated
- inability to follow 2 step commands
- chronic low back or hip pain
- history of substance abuse
- history of head trauma
- comorbid neurological disorder
- any uncontrolled medical condition
- pacemaker
- any condition where fatiguing contractions or resisted leg contractions are contraindicated
- inability to walk for 5 minute bouts on a treadmill with a harness supporting up to 50% of the body weight at 80% of over-ground self-selected walking speed.
- be between ages of 18-85
- be able to give informed consent
- Those listed above for stroke survivors
- History of Stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical College of Wisconsinlead
- Marquette Universitycollaborator
Study Sites (2)
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Marquette University
Milwaukee, Wisconsin, 53233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 25, 2019
First Posted
July 31, 2019
Study Start
December 20, 2018
Primary Completion
December 16, 2025
Study Completion
January 9, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share